Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa

Mostrar otras versiones (1)

BACKGROUND: Carbapenems, fluoroquinolones (FQs), and aminoglycosides (AGs) are key drugs for treating Pseudomonas aeruginosa infections, and accumulation of drug resistances make antibiotic therapy difficult. METHODS: We evaluated 169 patients with imipenem (IPM)-resistant P. aeruginosa and compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosai, Kosuke, Kaku, Norihito, Uno, Naoki, Saijo, Tomomi, Morinaga, Yoshitomo, Imamura, Yoshifumi, Hasegawa, Hiroo, Miyazaki, Taiga, Izumikawa, Koichi, Mukae, Hiroshi, Yanagihara, Katsunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481610/
https://www.ncbi.nlm.nih.gov/pubmed/28694882
http://dx.doi.org/10.2174/1874285801711010092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481610/
https://www.ncbi.nlm.nih.gov/pubmed/28694882
http://dx.doi.org/10.2174/1874285801711010092

Ejemplares similares